Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00025285 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: irinotecan hydrochloride
DRUG: thalidomide

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]